SCHEMBL4143264

SCHEMBL4143264

CCOC(=O)C(C)(C(=O)O)[C@@H]1c2ccccc2C[C@H]1NC(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.45
EPHX2 P34913 1/20 0.40
MAOB P27338 2/20 0.38
KDM1A O60341 2/20 0.38
KMT2A Q03164 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
DRD2 P14416 2/20 0.37
NFKB1 P19838 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36
AKT1 P31749 2/20 0.36
MAOA P21397 1/20 0.36
ALDH1A1 P00352 1/20 0.36
RECQL P46063 1/20 0.36
MMP8 P22894 1/20 0.36
PDE4B Q07343 1/20 0.35
IDO1 P14902 1/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3328789 0.84 ATM (0.41) ATMEPHX2MAOBKDM1AKMT2A
SCHEMBL4143259 0.84 EPHX2 (0.46) ATMEPHX2MAOBKDM1AKMT2A
SCHEMBL5324391 0.82 ATM (0.43) ATMEPHX2MAOBKDM1AKMT2A
SCHEMBL4157658 0.82 ATM (0.43) ATMEPHX2MAOBKDM1AKMT2A
SCHEMBL3323474 0.80 ATM (0.40) ATMEPHX2MAOBKDM1AKMT2A
SCHEMBL3323909 0.77 EPHX2 (0.41) ATMEPHX2MAOBKDM1AKMT2A
SCHEMBL13299071 0.77 ATM (0.40) ATMEPHX2MAOBKDM1AKMT2A
SCHEMBL3327727 0.76 EPHX2 (0.39) ATMEPHX2MAOBKDM1AKMT2A
SCHEMBL3328783 0.75 EPHX2 (0.41) ATMEPHX2MAOBKDM1AKMT2A
SCHEMBL13299061 0.75 DRD2 (0.44) ATMEPHX2MAOBKDM1AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090124682-A1 Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory Activity BIRCH ALAN MARTIN 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124682-A1 Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory Activity PYGL, PYGM, GYS1 ATM 2233/4885EPHX2 3678/4885MAOB 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.